Healthcare provider profile · identity verified

Jay R Muller, MD

Internal Medicine · FOND DU LAC, WI · NPI 1053305961

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1081	287
Losartan Potassium	Losartan Potassium	546	141
Omeprazole	Omeprazole	479	115
Lisinopril	Lisinopril	459	114
Gabapentin	Gabapentin	428	85
Levothyroxine Sodium	Levothyroxine Sodium	427	100
Amlodipine Besylate	Amlodipine Besylate	374	100
Sertraline Hcl	Sertraline Hcl	347	77
Pravastatin Sodium	Pravastatin Sodium	332	86
Hydrochlorothiazide	Hydrochlorothiazide	315	86
Metoprolol Succinate	Metoprolol Succinate	289	75
Metformin Hcl	Metformin Hcl	270	59
Metoprolol Tartrate	Metoprolol Tartrate	249	63
Pantoprazole Sodium	Pantoprazole Sodium	237	65
Fluticasone Propionate	Fluticasone Propionate	222	75
Tamsulosin Hcl	Tamsulosin Hcl	217	57
Rosuvastatin Calcium	Rosuvastatin Calcium	205	57
Trazodone Hcl	Trazodone Hcl	203	54
Glimepiride	Glimepiride	196	46
Warfarin Sodium	Warfarin Sodium	194	41
Simvastatin	Simvastatin	192	55
Albuterol Sulfate Hfa	Albuterol Sulfate	182	58
Furosemide	Furosemide	177	51
Allopurinol	Allopurinol	159	43
Metformin Hcl Er	Metformin Hcl	155	45
Potassium Chloride	Potassium Chloride	151	34
Eliquis	Apixaban	109	25
Ozempic	Semaglutide	106	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	22
Famotidine	Famotidine	101	26
Carvedilol	Carvedilol	100	30
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	95	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	30
Escitalopram Oxalate	Escitalopram Oxalate	88	19
Finasteride	Finasteride	87	22
Jardiance	Empagliflozin	83	21
Meloxicam	Meloxicam	76	26
Montelukast Sodium	Montelukast Sodium	74	19
Prednisone	Prednisone	73	46
Pregabalin	Pregabalin	73	13
Glipizide	Glipizide	72	17
Tramadol Hcl	Tramadol Hcl	69	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	68	19
Spironolactone	Spironolactone	65	19
Duloxetine Hcl	Duloxetine Hcl	64	19
Clopidogrel	Clopidogrel Bisulfate	61	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	59	13
Alendronate Sodium	Alendronate Sodium	58	20
Januvia	Sitagliptin Phosphate	58	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	56	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	52	12
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	49	suppressed
Tizanidine Hcl	Tizanidine Hcl	49	14
Azelastine Hcl	Azelastine Hcl	48	30
Propranolol Hcl Er	Propranolol Hcl	48	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	38
Ezetimibe	Ezetimibe	46	15
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Synthroid	Levothyroxine Sodium	44	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	24
Bumetanide	Bumetanide	40	13
Nystatin	Nystatin	40	21
Mounjaro	Tirzepatide	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Meclizine Hcl	Meclizine Hcl	38	23
Mirtazapine	Mirtazapine	38	12
Estradiol	Estradiol	37	suppressed
Amoxicillin	Amoxicillin	36	16
Enalapril Maleate	Enalapril Maleate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	34
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Glipizide Er	Glipizide	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Atenolol	Atenolol	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Risperidone	Risperidone	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	17
Trulicity	Dulaglutide	30	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	24
Lorazepam	Lorazepam	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cephalexin	Cephalexin	24	20
Tradjenta	Linagliptin	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	18
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Felodipine Er	Felodipine	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Wegovy	Semaglutide	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Nystop	Nystatin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Temazepam	Temazepam	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error